Stock research
LNAI Lunai Bioworks Inc.
Healthcare • Biotechnology
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A...…
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
3M change
-1.20%
Range high
$4.30
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in LNAI?
Price
Showing 3M history. Source: FMP historical price full.
- Prev Close
- $2.55
- Day High
- $2.75
- Day Low
- $2.37
- 52w High
- $21.20
- 52w Low
- $1.21
- Volume
- 101,437
- Avg Volume
- Beta
- 0.353
* TTM/most recent where available
Company
- Ticker
- LNAI
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- David H. Weinstein
- Employees
- 29
- Website
- www.lunaibioworks.com
Key Metrics
- Market Cap
- 11.2M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).